- Sequential therapy for Helicobacter pylori eradication: the time is now! Riferimento: Therapeutic Advances in Gastroenterology 2009; Vol 2(6):317-322.
Vaira D, Zullo A, Hassan C, Fiorini G, Vakil N.
- Helicobacter pylori: la nuova terapia. Riferimento: Elisir di salute 2009, nov-dic 2009: 35-37.
Vaira D, Fiorini G, Ricci C, Lanzini A.
- Infezione da Helicobacter pylori e nuovi orientamenti terapeutici: la terapia sequenziale. Riferimento: M.D. Medicinae Doctor 2009, anno XVI (num.33): 20-22.
Vaira D, Gatta L, Fiorini G, Castelli V, Di Mario F.
- La terapia gastroprotettiva nel paziente cardiopatico: un problema sempre attuale. Riferimento: La cardiologia nella pratica clinica 2009; Vol. 16 (1): 29-38.
Vaira D, Gatta L, Fiorini G, Borghi C.
- Nuovi orientamenti terapeutici per l’infezione da Helicobacter pylori: la terapia sequenziale. Riferimento: Italian Journal of Primary Care 2010; vol.2: pp. 120-124.
Vaira D, Gatta L, De Francesco V, Ricci C, Fiorini G, Castelli C, Ierardi E.
- Accuracy of a new ultra-fast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive dyspeptic patients. Riferimento: Alimentary Pharmacology & Therapeutics 2010; Vol 31 (2): 331-338. (I.F. 6.3)
Vaira D, Vakil N, Gatta L, Ricci C, Perna F, Saracino I, Fiorini G, Holton J.
- A comparison among three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptics. Riferimento: Internal and Emergency Medicine 2010; 1: 41-47
Vaira D, Gatta L, Ricci C, Perna F, Saracino I, Fiorini G, Castelli V, Holton J.
- A validation study of the Italian Short-Form Leeds Dyspepsia Questionnaire Riferimento: Internal and Emergency Medicine 2010; 5: 501-506
Gatta L, Moayyedi P, Tosetti C, Vakil N, Ubaldi E, Barsanti P, Fiorini G, Castelli V, Gargiulo C, Lucarini P, Lera M, Kaio E, Di Mario F, Vaira D.
- Proton pump inhibitors and antiplatelet drugs in clinical cardiology Riferimento: Cardiology in clinical practice Volume 2, Number 2, 1 May 2010, pp. 75-83(9).
Gatta L, Vaira D, Fiorini G, Borghi C.
- Nuovi orientamenti terapeutici per l’Infezione da Helicobacter pylori: La Terapia Sequenziale. Riferimento: Internal and Emergency Medicine 2010; vol.5; n1.
Vaira D, Gatta L, Fiorini G, Castelli C, Nasuto M, Di Mario F.
- Gastroesophageal Reflux Disease and Barrett’s Esophagus. Riferimento: Internal and Emergency Medicine 2011; 6:299-306
Vaira D, Gatta L, Ricci C, Castelli V, Fiorini G, Kaio E, Lanzini A.
- Helicobacter pylori eradication: Are we all equal? A controlled study in native and immigrant population. Riferimento: Internal and Emergency Medicine 2011; 6: 35-39.
Gatta L, Di Mario F, Vaira D, Franzé A, Rugge M, Pilotto A, Lucarini P, Lera M, Fiorini G, Castelli V, Kaio E, Scarpignato C.
- Valutazione di economia sanitaria sull’infezione da Helicobacter pylori. Riferimento: Farmaci 2011, Vol.10; 3:80-5.
Gatta L, Gargiulo C, Ricci C, Fiorini G, Castelli V, Caselli M, Vaira G, Papini F, Cassol F, Vaira D.
- Morphology and adesion to the epithelium of the terminal ileum of segmented filamentous bacterie. Effects on the relation with the immune system. Riferimento: Farmaci 2011, Vol 10; 5/6: 136-42.
Caselli M, Holton J, Cassol F, Boldrini P, Castelli V, Fiorini G, Saracino I., Zaccaro C, Vaira G, Papini F, Calò G, Vaira D.
- Le molecole strutturali batteriche come potenziali candidate per l’evoluzione del concetto classico di probiotici. Riferimento: NPT in Gastroenterologia 2011; 2/3: 3-10.
Caselli M, J Holton, Cassol F, Boldrini P, Ricci C, Gatta L, Castelli V, Fiorini G, Saracino I, Zaccaro C, Vaira G, Papini F, Calo’ G, Vaira D.
- Probiotici ricombinanti e loro potenziale sulla salute umana. Riferimento: Farmaci 2011;10 (4):109-113.
Caselli M, Holton J, Cassol F, Ricci C, Gatta L, Castelli V, Fiorini G, Saracino I, Vaira G, Papini F, Calò G, Vaira D.
- Sequenze genomiche dei batteri filamentosi segmentati negli animali da laboratorio. Implicazioni per la ricerca sull’uomo. Riferimento: NPT 2012, 1: 23-28.
Caselli M, Cassol F, Saracino I, Castelli V, Fiorini G, Ricci C, Zaccaro C, Vaira D.
- Ruolo dei batteri componenti la flora intestinale nell’eziopatogenesi della colite ulcerosa e del cancro del colon: i Fusobatteri e il Bacteroides fragilis enterotossico prendono la scena. Riferimento: Farmaci 2012, Vol.11(2): 46-50.
Caselli M, Cassol F, Saracino I, Castelli V, Fiorini G, Ricci C, Zaccaro C, Vaira D.
- Newer agents for Helicobacter pylori eradication. Riferimento: Clinical and Experimental Gastroenterology 2012:5 109–112.
Fiorini G, Zullo A, Gatta L , Castelli V, Ricci C, Cassol F , Vaira D.
- High Prevalence of Primary Antibiotic Resistance In Helicobacter pylori Isolates in Italy. Riferimento: Journal of Gastrointestinal and Liver Diseases 2012; 21(4):363-5.
Saracino IM, Zullo A, Holton J, Castelli V, Fiorini G, Zaccaro C, Ridola L, Ricci C, Gatta L, Vaira D.
- Culture based triple therapy using levofloxacin or rifabutin in patients who fail initial therapy. Riferimento: Clin Gastroenterol Hepatol 2013; 11: 507-513.
Fiorini G, Vakil N, Zullo A Saracino I.M., Castelli V, Ricci C, Zaccaro C, Gatta L, Vaira D.
- Therapy for h. pylori: current concepts. Riferimento: Open Journal of Gastroenterology 2013; 3: 38-41.
Fiorini G, Zullo A, Castelli V, Ricci C, Bellone F, Saracino IM, Zaccaro C, Verardi FM, Reggi A, Vaira D.
- Role of Helicobacter pylori infection in the thyroid diseases. Riferimento: Journal of Gastrointestinal and Liver Diseases 2013; Sep;22(3):261-263.
Fiorini G, Zullo A, Castelli V, Lo Re G,Vaira D.
- Diagnosi invasiva e non invasiva dell’infezione da Helicobacter pylori: endoscopia, istologia, coltura, test rapido all’ureasi, prove molecolari, test sierologico, urea breath test, test dell’antigene fecale. Riferimento: NPT in Gastroenterologia 2013; 2: 1-10.
Fiorini G, Caselli M, Saracino IM, Zaccaro C, Gualandi A, Vaira D.
- Change of point mutations in the H. pylori rRNA associated with clarithromycin resistance in Italy. Riferimento: Journal of Medical Microbiology 2014 Mar;63(Pt 3):453-7
De Francesco V, Zullo A, Giorgio F, Saracino I, Zaccaro C, Hassan C, Ierardi E, Di Leo A, Fiorini G, Castelli V, Vaira D.
- Diseases of the correlation between the upper gastrointestinal tract, chronic stress and body composition Riferimento: Farmaci 2014, 13 (2): 62-71.
Zaccaro C, Saracino IM, Boschiero D, Castelli V, Fiorini G, Ricci C,Vaira D.
- A systematic review on drugs absorption modifications after eradication in Helicobacter pylori positive patients undergoing replacement therapy. Riferimento: Journal of Gastrointestinal and Liver Diseases, 2015 Mar; 24(1):95-100
Fiorini G, Bland J.M, Hughes E, Castelli V, Vaira D.
- In vivo dissolution of levothyroxine soft gel capsules. Riferimento: Intern Emerg Med. 2016 11:1151–1152
Fiorini G, Ribichini D, Pasquali R, Vaira D.
- Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT. Riferimento: Internal and Emergency Medicine, 12(3), 333-339
Zaccaro C, Saracino IM, Fiorini G, Figura N, Holton J, Castelli V, Pesci V, Gatta L, Vaira D.
- Tablet and oral liquid L-Thyroxine formulation in the treatment of naive hypothyroid patients with Helicobacter pylori infection. Riferimento: Endocrine 2017, in press.
Ribichini D, Fiorini G, Repaci A, Castelli V, Gatta L, Vaira D, Pasquali R.
- A new non –invasive tool for guiding H pylori treatment. Journal of precision medicine Riferimento: Precision Medicine 2017, 3: e1597. (I.F 0.98)
Beckman E, Saracino I, Fiorini G, Clarck C, Slepnev V, Patel D, Gomez C. Ponaka R, Elagn V, Vaira D.
- Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori -resistant strains. Riferimento: Helicobacter. 2017 Dec;22(6).
Fiorini G, Saracino IM, Zullo A, Gatta L, Pavoni M, Vaira D.
- A Novel Stool PCR Test for Helicobacter pylori May Predict Clarithromycin Resistance and Eradication of Infection at a High Rate. Riferimento: J Clin Microbiol. 2017 Aug;55(8):2400-2405.
Beckman E, Saracino I, Fiorini G, Clark C, Slepnev V, Patel D, Gomez C, Ponaka R, Elagin V, VairaD.
- Cameron lesions: A still overlooked diagnosis. Case report and systematic review of literature. Riferimento: Clin Res Hepatol Gastroenterol. 2018 Dec;42(6):604-609
Zullo A, Manta R, De Francesco V, Fiorini G, Lahner E, Vaira D,Annibale B.
- Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016. Riferimento: Scand J Gastroenterol. 2018 Jun;53(6):661-664.
Fiorini G, Zullo A, Saracino IM, Pavoni M, Vaira D.
- Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains. Riferimento: Aliment Pharmacol Ther. 2018 May;47(9):1261-1269.
Gatta L, Scarpignato C, Fiorini G, Belsey J, Saracino IM, Ricci C, Vaira D.
- Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice. Riferimento: Eur J Gastroenterol Hepatol. 2018 Jun;30(6):621-625.
Fiorini G, Zullo A, Saracino IM, Gatta L, Pavoni M, Vaira D.
- Immune thrombocytopenic purpura and infections. Riferimento: Intern Emerg Med. 2018 Jul 20. doi: 10.1007/s11739-018-1908-9.
Ponzetto A, Figura N, Fiorini G.
- Whipple's disease: case report and review of the literature. Riferimento: J Gastrointestin Liver Dis. 2018 Sep;27(3):331-336
De Francesco V, Corsi F, Pennella A, Bellesia A, Fiorini G, Vaira D,Zullo A.
- Diagnostic yield of upper endoscopy according to appropriateness: A systematic review. doi: 10.1016/j.dld.2018.11.029. Riferimento: Digestive and Liver Disease 2019: 51; 335-39.
Zullo A, Manta R, De Francesco V, Fiorini G, Hassan C, Vaira D.
- Rifabutin triple therapy is effective in patients with multidrug-resistant strains of Helicobacter pylori. Riferimento: J Gastrointest Liver Dis 2018; 52: 137-140.
Fiorini G, Zullo A, Vakil N, Saracino IM, Ricci C, Castelli V, Gatta L, Vaira D.
- Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication. Riferimento: J Antimicrob Chemother 2019; 3: 772-74.
De Francesco V, Zullo A, Fiorini G, Saracino IM, Pavoni M, Vaira D.
- Diagnostic yield of upper endoscopy according to appropriateness: a Systematic review. Riferimento: Digestive and Liver Disease 2019: 51; 335-39.
Zullo A, Manta R, De Francesco V, Fiorini G, Hassan C, Vaira D.
- Efficacy of a New Nutraceutical formulation in patients with symptomatic uncomplicated diverticular disease (SUDD): a propspective observational Study. Riferimento: J Gastrointest Liver Dis 2019; 28: 49-52.
D’Amico F, Fiorini G, Tursi A, Saracino IM, Pavoni M, Danese S, Vaira D.
- Sequential therapy for first-line Helicobacter pylori eradication: 10- or 14- day regimen? Riferimento: J Gastrointest Liver Dis 2019; 28: 11-14.
Zullo A, Fiorini G, Scaccianoce G, Portincasa P, De Francesco V, Vassallo R, Urban F, Monica F, Mogavero G, Amato A, Vaira D.
- Paradigm shift: the Copernican revolution in diverticular disease. Riferimento: Ann Gastroenterol 2019;32: 541-553.
Zullo A, Gatta L, Vassallo R, De Francesco V, Manta R, Monica F, Fiorini G, Vaira D.
- Antibiotic resistance and therapy for H. pylori infection in immigrant patients managed in Italy. Riferimento: J Clin Med. 2020 May 1;9(5):1299.
Fiorini G, Saracino IM., Zullo A, Pavoni M., Saccomanno L., Lazzarotto T., Cavallo R., Antonelli G., Vaira D.
- Trends in primary antibiotic resistance in H pylori strains isolated in Italy between 2009 and 2019. Riferimento: Antibiotics (Basel). 2020 Jan 13;9(1):26.
Saracino IM, Fiorini G, Zullo A, Pavoni M, Saccomanno L, Vaira D.
- Antibiotic resistance and therapy outcome in H. pylori eradication failure patients. Riferimento: Antibiotics (Basel). 2020 Mar 13;9(3):121.
Saracino IM., Pavoni M., Zullo A., Fiorini G., Saccomanno L., Lazzarotto T., Cavallo R., Antonelli G., Vaira D.
- Clinical performance of automated liaison meridian H pylori SA Stool antigen test. Riferimento: BioMed Res Int 2020:7189519. doi: 10.1155/2020/7189519. eCollection 2020 (I.F. 2.6)
Opekun AR., Zierold C., Rode A., Blocki F.A., Fiorini G., Saracino IM., Vaira D., Sutton FM.
- Efficacy of a new nutraceutical formulation (CHETOGERD) in patients with nonerosive reflux (NERD): a prospective observational study. Riferimento: Intern Emerg Med. 2020; 12: 333-39.
Fiorini G., Saracino I.M, Pavoni M., Saccomanno L., Vaira D.
- Endoscopic submucosal dissection of gastric neoplastic lesions in western countries: systematic review and metanalisys. Riferimento: Eur J Gastroenterol Hepatol. 2020 Aug 14. doi: 10.1097/MEG.0000000000001886.
Zullo A, Manta R., De francesco V., Manfredi G., Buscarini E, Fiorini G., Vaira D., Marmo R.
- Helicobacter pylori infection in psoriatic patients during biological therapy. Riferimento: G Ital Dermatol Venereol. 2020 Feb 5. doi: 10.23736/S0392-0488.19.06410-1.
Bardazzi F, Magnano M, Fiorini G, Vaira D, Odorici G, Bertusi G, Patrizi A.
- Upper endoscopy in patients with extra-oesophageal reflux symptoms: A multicenter study. Riferimento: GE Port J Gastroenterol. 2020 Aug;27(5):312-317
Zullo A, Fiorini G, Bassotti G, Bacchetti F, Monica F, Macor D, Paoluzi OA, Scaccianoce G, Portincasa P, De Francesco V, Lorenzetti R, Saracino IM, Pavoni M, Vaira D.
- Severe impaired blood pressure control caused by baroreflex failure as a late sequela of neck irradiation. Riferimento: J Hypertens. 2020 Mar; 38(3):553-556.
Piani F, Landolfo M, Fiorini G, D'Addato S, Mancia G, Borghi C.
- Nephrotic range proteinuria and acute heart failure. Riferimento: Intern Emerg Med. 2020 Jan; 15(1):105-108. doi: 10.1007/s11739-019-02029-z.
Landolfo M, Fiorini G, Borghi C.
- Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection. Riferimento: Eur J Intern Med. 2020 Nov; 81:50-53.
Saracino IM, Pavoni M, Zullo A, Fiorini G, Saccomanno L, Lazzarotto T, Antonelli G, Cavallo R, Borghi C, Vaira D
- Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter pylori. Riferimento: Antibiotics (Basel). 2020 May 11;9(5):244.
Saracino IM, Pavoni M, Saccomanno L, Fiorini G, Pesci V, Foschi C, Piccirilli G, Bernardini G, Holton J, Figura N, Lazzarotto T, Borghi C, Vaira B.
- European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients Riferimento: GUT. 2021 Jan; 70(1):40-54. doi: 10.1136/gutjnl-2020-321372.
Nyssen OP, Bordin D, Tepes B....Fiorini G, et al.
- Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013-2020: Results of the European Registry on H. pylori Management (Hp-EuReg). Riferimento: Antibiotics (Basel). 2021 Sep 1;10(9):1058. doi: 10.3390/antibiotics10091058.
Bujanda L, Nyssen OP, Vaira D, Saracino IM, Fiorini G, Lerang F, Georgopoulos S, Tepes B, Heluwaert F, Gasbarrini A, Rokkas T, Bordin D, Smith S, Lamy V, Caldas M, Resina E, Muñoz R, Cosme Á, Puig I, Megraud F, O'Morain C, Gisbert JP; The Hp-EuReg Investigators.
- The Role of Statins on Helicobacter pylori Eradication: Results from the European Registry on the Management of H. pylori (Hp-EuReg). Riferimento: Antibiotics (Basel). 2021 Aug 11;10(8):965. doi: 10.3390/antibiotics10080965.
Caldas M, Pérez-Aisa Á, Tepes B, et al. the Hp-EuReg Investigators.
- Rescue Therapies for H. pylori Infection in Italy. Riferimento: Antibiotics (Basel). 2021 May 3;10(5):525.
De Francesco V, Zullo A, Gatta L, Manta R, Pavoni M, Saracino IM, Fiorini G, Vaira D.
- Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter pylori: A Literature Review. Riferimento: Antibiotics (Basel). 2021 Apr 14;10(4):437.
Saracino IM, Pavoni M, Zullo A, Fiorini G, Lazzarotto T, Borghi C, Vaira D.
- Helicobacter pylori eradication following first-line treatment failure in Europe: What, how and when chose among different standard regimens? A systematic review. Riferimento: Eur J Gastroenterol Hepatol. 2021 Mar 19. doi: 10.1097/MEG.0000000000002100.
De Francesco V, Zullo A, Manta R, Gatta L, Fiorini G, Saracino IM, Vaira D.
- Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg). Riferimento: Am J Gastroenterol. 2021 Jun 1;116(6):1220-1229. doi: 10.14309/ajg.0000000000001246.
Nyssen OP, Perez-Aisa A, Tepes B, et al. Hp-EuReg Investigators.
- Design of optical cavity for air sanification through ultraviolet germicidal irradiation. Riferimento: Opt Express. 2021 Jun 7;29(12):18688-18704.
Lombini M, Diolaiti E, De Rosa A, Lessio L, Pareschi G, Bianco A, Cortecchia F, Fiorini M, Fiorini G, Malaguti G, Zanutta A.
- Gout, urate-lowering drugs, and risk of cardiovascular disease: can we clinically trust in the adjusted real-life data? Riferimento: Eur Heart J. 2021 Nov 21;42(44):4589-4591. doi: 10.1093/eurheartj/ehab667.
Borghi C, Fiorini G.
- Rescue Therapies for Helicobacter pylori Infection in Foreign Patients Treated in Italy. Riferimento: J Clin Gastroenterol. 2021 Nov-Dec 01;55(10):865-868. doi: 10.1097/MCG.0000000000001457.
Saracino IM, Pavoni M, Zullo A, Fiorini G, Saccomanno L, Lazzarotto T, Antonelli G, Cavallo R, Borghi C, Vaira D.
- The role of the occupational physician in controlling gastric cancer attributable to Helicobacter pylori infection: A review. Riferimento: Prev Med Rep. 2021 Aug 18;24:101527. doi: 10.1016/j.pmedr.2021.101527.
Collatuzzo G, Fiorini G, Vaira B, Violante FS, Farioli A, Boffetta P.
- Renin-angiotensin system modulation and outcomes in patients hospitalized for interstitial SARS-CoV2 pneumonia: a cohort study Riferimento: Intern Emerg Med. 2022 Aug;17(5):1335-1341. doi: 10.1007/s11739-022-02929-7
Landolfo M, Maino A, Di Salvo E, Fiorini G, Peterlana D, Borghi C.
- Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg). Riferimento: J Clin Med. 2022 Mar 16;11(6):1658. doi: 10.3390/jcm11061658.
Nyssen OP, Vaira D, Saracino IM, Fiorini G, Caldas M, Bujanda L, Pellicano R, Keco-Huerga A, Pabón-Carrasco M, Oblitas Susanibar E, Di Leo A, Losurdo G, Pérez-Aísa Á, Gasbarrini A, Boltin D, Smith S, Phull P, Rokkas T, Lamarque D, Cano-Català A, Puig I, Mégraud F, O'Morain C, Gisbert JP.
- Room for Improvement in the Treatment of Helicobacter pylori Infection: Lessons from the European Registry on H. pylori Management (Hp-EuReg). Riferimento: J Clin Gastroenterol. 2022 Feb 1;56(2):e98-e108.
Nyssen OP, Vaira D, Tepes B,et al. Hp-EuReg Investigators.
- Black Garlic and Pomegranate Standardized Extracts for Blood Pressure Improvement: A Non-Randomized Diet-Controlled Study. Riferimento: Appl. Sci. 2022; 12(19):9673. doi: 10.3390/app12199673
Fogacci F, Di Micoli A, Grandi E, Fiorini G, Borghi C, Cicero AFG.
- First-line therapies for H. pylori infection in Italy: a pooled-data analysis. Riferimento: Acta Gastroenterol Belg. 2022 Apr-Jun;85(2):295-299. doi: 10.51821/85.2.9680.
De Francesco V, Zullo A, Manta R, Pavoni M, Saracino IM, Fiorini G, Giostra F, Monti G, Vaira D.
- Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review. Riferimento: Ann Gastroenterol. 2022 Mar-Apr;35(2):127-134. doi: 10.20524/aog.2022.0689. Epub 2022 Feb 14.
Francesco V, Zullo A, Manta R, Satriano A, Fiorini G, Pavoni M, Saracino IM, Giostra F, Monti G, Vaira D.
Padronanza del Pacchetto Office (Word Excel PowerPoint ecc) Social Network Gestione autonoma della posta e-mail Microsoft Office Android GoogleChrome InternetExplorer Posta elettronica
COMPETENZE LINGUISTICHE Lingua madre: Italiano Altre lingue: inglese ASCOLTO C1 LETTURA B2 SCRITTURA B2 PRODUZIONE ORALE C1 INTERAZIONE ORALE C1 francese ASCOLTO A2 LETTURA A2 SCRITTURA A1 PRODUZIONE ORALE A2 INTERAZIONE ORALE A2 PATENTE DI GUIDA Automobile: BAutorizzo il trattamento dei miei dati personali presenti nel CV ai sensi dell’art. 13 d. lgs. 30 giugno 2003 n. 196 - “Codice in materia di protezione dei dati personali” e dell’art. 13 GDPR 679/16 - “Regolamento europeo sulla protezione dei dati personali”.